Staging preview: health content pending qualified review
D2C Peptides

Healing and Recovery Peptides

This category holds the healing and recovery compounds in our catalog, including BPC-157, TB-500, KPV, GHK-Cu and IGF-1, each labeled for research use only and shipped from the USA and Canada to addresses across the United States.

Wholesale and bulk

Shop by category

Recovery is the catalog name for this group, and FDA describes the human data on several of its compounds as limited or absent.2 On July 23, 2026, FDA's Pharmacy Compounding Advisory Committee reviewed three of these compounds: BPC-157 for ulcerative colitis, TB-500 for wound healing, and KPV for wound healing and inflammatory conditions.1 FDA's career scientists recommended against adding any of them to the 503A bulks list, and trade press reported that the committee voted 8 to 6, with 1 abstention, in favor.3 As of October 25, 2026, that list in federal regulations still names no peptide.6 For KPV, FDA says it has not identified any human exposure data on drug products that contain it.2

HGH, IGF-1 and several growth hormone releasing peptides also sit in this category. The compounding and sport status of GHRP-2, GHRP-6, CJC-1295 and Ipamorelin is set out on the growth hormone peptides page. For a map of the healing research by compound, with evidence levels, read the healing goal guide.

13 products
Shop all peptidesShop supplies

All categories

Ordering facts

Orders ship from the USA and Canada to addresses across the United States, and each product page shows where its strengths ship from; the shipping page has the details. The returns page explains returns, and the lab results page lists testing documents as they become available. Storage steps for vials before and after mixing are in the storage guide.

Frequently asked questions

Why can't you buy BPC 157 anymore?

BPC-157 is still sold here, labeled for research use only. The restrictions are on pharmacy compounding. FDA placed BPC-157 in Category 2, its group for significant safety concerns, and after the nominators withdrew it FDA still lists possible immune reactions, impurity problems and too little safety information to know whether it would harm people.2 An FDA advisory committee narrowly backed it for compounding in July 2026, but FDA must still accept that nonbinding vote and go through rulemaking.3

Where can I buy TB500 peptide?

TB-500 is in this category, and the TB-500 product page lists its strengths, price and stock. Before planning work with it, note what regulators have recorded. FDA says it has not identified any human exposure data for TB-500, which it lists as a fragment of thymosin beta-4 (LKKTETQ).2 WADA's 2026 list bans thymosin beta-4 derivatives such as TB-500 at all times.4 TB-500 is also sold with BPC-157 in one vial as the Wolverine Stack.

Is BPC-157 approved by the FDA for human use?

No. The US Anti-Doping Agency says BPC-157 is not approved for human clinical use by FDA or by any other health authority in the world.5 WADA's 2026 list bans it at all times as a non-approved substance.4 When FDA's advisory committee reviewed BPC-157 in July 2026, the use on the table was ulcerative colitis, not injury repair.1 The BPC-157 education page reviews the published studies.

Sources

  1. July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee. US Food and Drug Administration, 2026.
  2. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. US Food and Drug Administration, 2026.
  3. FDA Panel Backs 6 Peptides for Compounding (July 31, 2026). AJMC (The American Journal of Managed Care), 2026.
  4. World Anti-Doping Code International Standard: Prohibited List 2026. World Anti-Doping Agency (WADA), 2025.
  5. BPC-157: What Athletes Should Know About the Prohibited Experimental Peptide. U.S. Anti-Doping Agency (USADA), 2026.
  6. 21 CFR 216.23 Bulk drug substances that can be used to compound drug products in accordance with section 503A of the FD&C Act. Electronic Code of Federal Regulations (eCFR), 2026.